Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison

Published:2016-05 Issue:1 Volume:8 Page:74-82
ISSN:1759-1104
Container-title:Heart Asia
language:en
Short-container-title:Heart Asia

Author:

Wang Chen,Jing Zhi-Cheng,Huang Yi-Gao,Zhou Da-Xin,Liu Zhi-Hong,Meier Christian,Nikkho Sylvia,Curram John,Zhang Peng,He Jian-Guo

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galiè;Eur Heart J,2016

2. Mechanisms of disease: pulmonary arterial hypertension;Schermuly;Nat Rev Cardiol,2011

3. Chronic thromboembolic pulmonary hypertension;Kim;J Am Coll Cardiol,2013

4. Novel medical therapies for pulmonary arterial hypertension;O'Connell;Clin Chest Med,2013

5. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry;Benza;Chest,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in targeted therapy for pulmonary arterial hypertension in children;European Journal of Pediatrics;2022-12-17

2. Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study;ERJ Open Research;2021-07

3. Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension;Medicine;2021-06-04

4. Riociguat Improves Pulmonary Hemodynamics in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension;ACTA CARDIOL SIN;2020

5. A meta‐analysis of randomized controlled trials in targeted treatments of chronic thromboembolic pulmonary hypertension;The Clinical Respiratory Journal;2019-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3